...was VP of external science and innovation at Allergan plc (NYSE:AGN). Progressive kidney disease company Xortx...
...Inc. (CSE:XRX; OTCQB:XRTXF) hired James Fairbairn as CFO. He succeeds Dave Matthews, who was named Xortx...

...NYSE:PFE) Bosulif bosutinib Dual inhibitor of BCR-ABL tyrosine kinase (BCR-ABL) and Src PKD Phase II Xortx Pharma Corp....